Tau PET imaging in Black and Latino participants with and without cognitive impairment

Abstract

Background: Tau‐PET neuroimaging is increasingly applied to diagnose and stage, track progression, and assess response to putative disease‐modifying treatments in individuals with Alzheimer disease.